CD2H COVID-19

A Retrospective Study of COVID-19 Treatments

Purpose

Surveys administered to subjects who have recovered from COVID-19 to assess how effective their treatment was.

Conditions

Covid19
COVID-19 Pneumonia
COVID-19 Respiratory Infection
COVID-19 Acute Bronchitis
COVID-19 Acute Respiratory Distress Syndrome
COVID-19 Lower Respiratory Infection
SARS-CoV2 Infection
SARS-CoV-2 Acute Respiratory Disease

Eligibility

Eligible Ages: Over 18 Months
Eligible Sex: All
Accepts Healthy Volunteers: No

Inclusion Criteria

Signed informed consent, demonstrating that the patient understands the procedures required for the study and the purpose of the study 2. Male or female of 18 years of age or older 3. Diagnosis of COVID-19 infection by RT- PCR 4. Recovery from COVID-19

Exclusion Criteria

Study Design

Phase
Study Type: Observational
Observational Model: Case-Only
Time Perspective: Retrospective

Arm Groups

Arm	Description	Assigned Intervention
COVID-19 Patients	Subjects who have recovered from COVID-19	Other: No Intervention Used There is no intervention in this study

Recruiting Locations

More Details

NCT ID: NCT04949230
Status: Completed
Sponsor: ProgenaBiome

Detailed Description

Subjects who have recovered from COVID-19 will answer questions regarding the severity of their illness, symptoms experienced, what treatment they received, and how long they were ill.

Notice

Study information shown on this site is derived from ClinicalTrials.gov (a public registry operated by the National Institutes of Health). The listing of studies provided is not certain to be all studies for which you might be eligible. Furthermore, study eligibility requirements can be difficult to understand and may change over time, so it is wise to speak with your medical care provider and individual research study teams when making decisions related to participation.